WHO WE ARE WHAT WE DO OUR AGENCIES JOIN US NEWS CONTACT US Onyx is a specialist agency with a laser focus on orphan drugs/rare diseases, regenerative medicine including gene therapy, biosimilars and innovative medical technologies where significant unmet clinical needs exist. Building on our deep heritage in orphan drugs/rare diseases and regenerative medicines, Onyx delivers engaging made-to-measure programmes which successfully overcome the significant and very specific communications challenges such areas present. Onyx reflects our ability to navigate complex science and our commitment to developing communications for therapies at the cutting edge of medicine using a mix of traditional channels, exciting new innovations in the digital space and avant-garde creativity. Mantra. Cutting-edge healthcare. Cutting-edge communications. Recent Highlights. Cell Therapy Manufacturing & Gene Therapy Congress in Brussels 2016 Howard Sinclair presenting at the Cell Therapy Manufacturing & Gene Therapy Congress in Brussels earlier this year, a particular honour for the Onyx team. Vacancies. We’re always looking for brilliant people to join our teams! Click the link to find out more about becoming part of Prime Global, view available roles, and apply. Join us Interesting Challenges. Random Fact. An estimated 350 million people worldwide have a rare disease and 30% of children with rare diseases die before their 5th birthday.* Thirty-five percent of deaths in the first year of life are caused by rare diseases.* *Source: www.globalgenes.org News. How can we make lung cancer trials more patient-centric? Prime Global 22 November, 2021 In recognition of Lung Cancer Awareness Month, Olivia Kersey, Patient Engagement Strategist, illustrates current opportunities for the pharmaceutical industry to better meet lung cancer patients’ needs across clinical trials and beyond. read more >> Industry Awareness, Media, News, Prime Patient clinical trials, Medical Communications, patient engagement, Prime Global Your guide to patient authorship Prime Global 17 November, 2021 Patient involvement in clinical trial design has evolved to provide opportunity for patients to be involved in medical publications. This evolution has allowed medical publications to gain invaluable patient perspectives on clinical research, by involving patients as authors in the development of plain language summaries and other, more traditional types of research publications1. read more >> Industry Awareness, Media, News, Prime Patient Medical Communications, patient engagement, Prime Global An interview with Kirsty Anderson, Digital Project Lead Prime Global 17 November, 2021 Kirsty Anderson, Digital Project Lead, took the time to discuss all things digital with us! In this interview, she shares insight into her role, the challenges and opportunities of a digital project, and her views on the future of digital. read more >> Industry Awareness, Interview, Media, News careers, Medical Communications, Prime Global Get in touch. We’re always happy to hear from you Use the contact form or get full details for each of our offices around the world. Contact us The Medical Communications People © Prime Global Medical Communications Ltd. Company Number 3642172 Privacy Policy | Cookie Policy